| Financial Year |
March 31 2023 |
| Monetary Funds |
1,354,532,516.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,109,745.80 |
| Accounts Receivable |
118,734,457.16 |
| Advances to Suppliers |
9,943,688.67 |
| Other Receivables |
241,499,845.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
111,350,361.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
159,729,403.43 |
| Total Current Assets |
2,004,219,747.94 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,590,377.49 |
| Investment Properties |
-- |
| Fixed Assetes |
9,135,378.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,487,650.82 |
| R&D expenses |
-- |
| Goodwill |
103,967,901.25 |
| Long-Term Deferred and Prepaid Expenses |
1,626,215.85 |
| Deferred Income Tax Assets |
21,695,978.29 |
| Other Non-Current Assets |
1,000,000.00 |
| Sub-Total of Non-Current Assets |
299,581,628.96 |
| Total Assets |
2,303,801,376.90 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
39,574,728.03 |
| Accounts Received In Advance |
371,527.94 |
| Employee Compensation Payable |
14,686,967.45 |
| Taxes Payable |
7,689,358.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
58,170,624.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,377,727.31 |
| Other Current Liabilities |
17,314,403.30 |
| Sub-Total of Current Liabilities |
198,740,358.18 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,555,776.48 |
| Deferred Income Tax Liabilities |
5,297,993.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
115,602,690.96 |
| Total Liabilities |
314,343,049.14 |
| Paid-In Capital(Or Share Stock) |
906,214,651.00 |
| Capital Surplus |
1,416,188,564.86 |
| Surplus Reserve |
215,688,541.29 |
| LESS:Treasury Stock |
18,622,118.40 |
| Undistributed Profits |
-516,658,060.57 |
| Minority Stockholder's Interest |
-138,539.56 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,989,596,867.32 |
| Owner's Equity（Stockholder's Equity） |
1,989,458,327.76 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,303,801,376.90 |
